首页/数据集/Heterogeneity in MYC-Induced Mammary Tumors Determines Outcomes Following Loss of Myc Activity

Heterogeneity in MYC-Induced Mammary Tumors Determines Outcomes Following Loss of Myc Activity

ChEBI2010-07-08 更新2026-07-21 收录

乳腺肿瘤异质性

MYC癌基因

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-22406 数据链接链接失效反馈

官方服务：

资源简介：

Heterogeneity in MYC-Induced Mammary Tumors Determines Outcomes Following Loss of Myc Activity

应用场景：

创建时间：

2010-07-08

肝癌发生

MYC癌基因

Hepatocarcinogenesis is a multi-stage process in which precursor lesions progress into early hepatocellular carcinomas (eHCC) by sequential accumulation of multiple genetic and epigenetic alterations.

NIAID Data Ecosystem80

Genome-wide maps of RNA polymerase II occupancy and transcriptome profile in response to expression of ectopic MYC proteins in immortalized MEF cells. Genome-wide maps of RNA polymerase II occupancy and transcriptome profile in response to expression of ectopic MYC proteins in immortalized MEF cells

转录调控机制

MYC癌基因

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series

NIAID Data Ecosystem50

Psoralen-modified clamp-forming antisense oligonucleotides reduce cellular c-Myc protein expression and B16-F0 proliferation

反义寡核苷酸

MYC癌基因

The c-myc protooncogene plays an important role in the abnormal growth pattern of melanoma cells. In an attempt to inhibit c-Myc expression and the growth of an established murine melanoma cell line,

PubMed Central2001-10-01 更新40

MYC Transactome Mapped by Global Array-based Nuclear Run-on (ANRO - Affymetrix)

基因转录调控

MYC癌基因

We describe and illustrate the use of a method to measure nascent nuclear gene transcription with an Array-based Nuclear Run-On (ANRO) assay using commercial microarray platforms. ANRO measurements in

NIAID Data Ecosystem70

Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13

卵巢癌治疗

MYC癌基因

High-grade serous ovarian cancer is characterized by extensive copy number alterations, among which the amplification of MYC oncogene occurs in nearly half of tumors. We demonstrate that ovarian cance

NIAID Data Ecosystem50

Heterogeneity in MYC-Induced Mammary Tumors Determines Outcomes Following Loss of Myc Activity

资源简介：

相关数据集